ATC Group: C05CA03 Diosmin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C05CA03 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C05 Vasoprotectives
3 C05C Capillary stabilizing agents
4 C05CA Bioflavonoids
5 C05CA03 Diosmin

Active ingredients in C05CA03

Active Ingredient Description
Diosmin

Diosmin (diosmetin 7-O-rutinoside), a flavone derivative also known as venosmine, is a glycoside of diosmetin, which in turn is the 4'-methoxy derivative of luteolin. Diosmin prolongs the vasoconstrictor effect of norepinephrine on the vein wall, increasing venous tone, and therefore reducing venous capacitance, distensibility, and venous stasis. This increases the venous return and reduces venous hyperpressure present in patients suffering from CVI.

Medicines in this ATC group

Brazil (BR)

Croatia (HR)

Ecuador (EC)

Estonia (EE)

Hong Kong (HK)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Nigeria (NG)

Romania (RO)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.